Encompass Health Corporation
EHC | NYSE
$124.23
+$2.67 (+2.20%)
Sep 22, 2026, 11:48 AM ET · Market open
Market Data
Market Cap $12.06B
Enterprise Value $14.79B
Beta 0.61
Average Volume 983.61K
Shares Outstanding (Diluted) 100M
Shares Change YoY -2.15%
Institutional Ownership 97.10%
Exchange NYSE
ISIN US29261A1007
Price Performance
Price Change 1M 1.0%
Price Change 3M 21.7%
Price Change 6M 23.0%
Price Change YTD 14.3%
Price Change 1Y -3.5%
Price Change 3Y 72.7%
Price Change 5Y 98.5%
1M CAGR (ann.) -2.9%
1Y CAGR (ann.) -2.3%
5Y CAGR (ann.) 15.7%
All-Time CAGR 10.8%
Valuation
PE Ratio 19.80
Forward PE 17.94
PEG Ratio 0.98
Forward PEG 2.12
PS Ratio 1.94
Forward PS 1.70
PB Ratio 4.64
P/FCF Ratio 21.38
P/Adj. FCF Ratio 23.83
P/OCF Ratio 9.91
EV/Sales 2.38
EV/EBIT 12.82
EV/EBITDA 9.86
EV/FCF 26.22
Earnings Yield 5.0%
FCF Yield 4.7%
Adj. FCF Yield 4.2%
Financial Health
Net Debt $2.53B
Total Debt $2.84B
Cash & Short-Term Investments $107.7M
Total Assets $7.46B
Current Ratio 1.19
Quick Ratio 1.19
Debt / Equity Ratio 1.09
Debt / EBITDA 1.89
Debt / FCF 5.04
OCF / Debt 0.54
Interest Coverage 8.89
Altman Z-Score 3.18
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 73.1%
Operating Profit Margin 18.0%
EBITDA Margin 24.2%
Net Profit Margin 10.0%
FCF Margin 9.1%
Adj. FCF Margin 8.2%
SBC / Revenue 0.9%
SBC Impact (per share) -10.3%
Returns
Return on Assets 8.3%
Return on Equity 25.0%
Return on Invested Capital 13.4%
Return on Capital Employed 17.0%
Return on Tangible Assets 10.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 10.7%
Revenue CAGR 5Y 4.8%
Revenue CAGR 10Y 6.1%
EPS CAGR 3Y 25.6%
EPS CAGR 5Y 9.8%
EPS CAGR 10Y 10.5%
FCF CAGR 3Y 70.5%
FCF CAGR 5Y 6.7%
FCF CAGR 10Y 3.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 27
EPS Growth Next 3Y 10.7%
Revenue Growth Next 3Y 10.1%
Earnings Date Oct 27, 2026
EPS Estimate (next Q) $1.38
EPS Growth Est (next Q) 12.2%
Revenue Est (next Q) $1.6B
Revenue Growth Est (next Q) 8.4%
Fair Value Estimates
Graham Number $69.57
Graham Upside -42.8%
Lynch Fair Value $60.42
Lynch Upside -50.3%
Price Target $150.25
Price Target Upside 23.6%
Cash Flow
Operating Cash Flow $1.53B
Free Cash Flow $564.1M
Adj. Free Cash Flow $506.1M
FCF Per Share $4.18
OCF Per Share $12.27
OCF/S Ratio 19.5%
Income Statement
Revenue $6.21B
Gross Profit $4.54B
Operating Income $1.12B
EBITDA $1.5B
Net Income $621M
EPS (Diluted) $6.14
Revenue / Employee $208.97K
Profit / Employee $20.91K
Employees 29,699
Dividends
Annual Dividend $0.76
Dividend Yield 0.63%
Payout Ratio 12.4%
FCF Payout Ratio 16.9%
Adj. FCF Payout Ratio 18.9%
Dividend Growth (YoY) 11.8%
Pay Frequency Quarterly
Ex-Dividend Date Sep 30, 2026
Add to Watchlist
Select watchlists to add or remove EHC